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Dengue virus runs rampant across Africa, Americas, Eastern Mediterranean, South-east Asia, and the Western Pacific with the South-east Asia and Asia-Pacific regions being 
the most seriously affected [1]. It transmits through vectors (Aedes 
aegypti mosquito) which thrive in many developing countries. The 
epidemiological season for dengue infection reaches its peak when 
vector growth ascends; normally during the monsoon season. Dengue 
outbreaks are very stereotypical in countries with cyclical monsoons.
In India, the World Health Organization and National Vector 
Borne Disease Control Programme quoted a figure of 99,913 
dengue cases and 220 deaths in 2015 [2,3]. It is quite comprehensible 
that during these outbreaks, there is an underdiagnosis of 
other illnesses whose presentations involve thrombocytopenia. 
Immune thrombocytopenic purpura (ITP) is another such disease 
characterized by destruction of platelet cells in the peripheral blood. 
It can present both in a primary or secondary manner [4]. Dengue 
and ITP share a common immunological flaw that precedes a 
downswing in the platelet cell numbers. Dengue is known to induce 
and provoke an aberrant immune system response [5-8].
This case series provides an apt portrayal of how illnesses with 
similar presentation can be misread by unearthing ITP in a sea of 
dengue and the versatility of ITP in particular. A literature search 
linking an association between the two was unfeasible due to its 
scarcity. It also demonstrates the multiple patterns of presentation 
of ITP, i.e., primary and secondary.
CASE REPORTS
A case series was conducted in our tertiary center of Punjab, India, 
among two patients during a period encompassing a surge in the 
cases of dengue fever in this particular geographical area (midst of 
a dengue outbreak). All the patients were adults between the ages 
of 18 years and 67 years, admitted with an acute history of fever 
with or without bleeding manifestations along with laboratory 
evidence of a low or declining platelet count almost clinically 
suggestive of dengue fever. Of the 184 patients that presented 
to us over a period of 2 months (December 1, 2017–January 31, 
2018), one was documented to have a primary ITP, and the other 
had secondary ITP.
The criteria and evaluation for ITP were followed as per the 
guidelines available [9]. In both cases, other myriad of conditions 
including other systemic illnesses (including systemic lupus 
erythematosus, hepatitis C infection, human immunodeficiency 
virus (HIV) infection, autoimmune thrombocytopenia, and liver 
disease) drug usage, and other primary hematologic disorders/
malignancies, history of bleeding after previous surgery, dentistry, 
and trauma, recent blood transfusions, recent vaccinations, family 
history of thrombocytopenia or bleeding disorders were ruled out 
historically. The history and examination pertaining to the cases 
and other relevant details of each of them are mentioned below.
Case 1
A 56-year old female without any prior comorbidity presented to 
us with generalized weakness and thrombocytopenia. Her vitals 
were as follows pulse - 62/min, blood pressure - 134/72 mmHg, 
and respiratory rate - 20/min. She did not have any abnormal 
physical findings, any organomegaly and lymphadenopathy apart 
from a mucosal bleeding and hemorrhagic crusting over her soft 
palate. Her platelet counts were found to be 4000 cells/mm3 with 
ABSTRACT
In this age of enhanced diagnostics and improved turnaround time, immune thrombocytopenic purpura (ITP), a disease primarily 
diagnosed by exclusion, is expected to be straightforward to diagnose. However, during a full-fledged dengue outbreak, the 
health-care system can be overwhelmed, and as a result, ITP can be underdiagnosed. The clinician should be aware of the various 
imitations that ITP can present with. Various clinical indicators have to be kept in mind while dealing with such an outbreak to avoid 
unnecessary health-care expenditure and prolonged hospital stays. In this case series, we present two patients diagnosed to have ITP 
during the dengue outbreak, each unique in its presentation and course, demonstrating the multiple patterns ITP can present itself.
Key words: Dengue, Fever, Immune thrombocytopenic purpura, Thrombocytopenia
Kodiatte and Kumar Dengue and ITP
Vol 5 | Issue 1 | Jan - Feb 2019 Indian J Case Reports 2
the peripheral blood film confirming the same, dengue IgM and 
NS1 antigen were negative apart from an otherwise normal blood 
investigation. She was transfused random donor platelets and 
single donor platelets (SDP) following which she persisted to 
have a low platelet count (3000 cells/mm3).
On day 3 of hospitalization, due to persistent thrombocytopenia 
refractory to donor platelet transfusions, an ITP was suspected. 
Bone marrow aspiration and biopsy were consistent with 
ITP (Increased megakaryopoiesis and other hematopoietic 
lineages being normal). She was started on oral corticosteroids 
(prednisolone) after which her platelet counts steadily rose to 
74,000 cells/mm3. She was diagnosed to have primary ITP and 
discharged on oral prednisolone. On follow-up a week later, she 
had platelet count of 230,000 cells/mm3.
Case 2
A 22-year old man, without any prior comorbidity, presented with 
a history of fever for 3 days followed by a steady fall in platelet 
count. The physical examination did not reveal any organomegaly, 
lymphadenopathy, or any other abnormality. His vitals were 
as follows: Pulse -  84/min, blood pressure - 110/80 mmHg, 
and respiratory rate - 20/min. He was admitted and found to 
have a platelet count of 3000 cells/mm3 (peripheral blood film 
confirming the same), dengue NS1 antigen and dengue IgM 
positive with the rest of the blood investigations being normal. 
He was diagnosed to have dengue fever without warning signs 
and was transfused 2 SDPs over the next 2 days (his platelet count 
rose to 23,000 cells/mm3) after which there was a spontaneous, 
unprovoked rise in platelet count (up to 65,000/mm3). He was 
discharged in an ambulatory condition.
On follow-up a week later, he was clinically found to be 
normal but had a platelet count of 36,000 cells/mm3. A week later, 
his platelet count was 23,000 cells/mm3. Each of these times, 
his peripheral blood films confirmed the thrombocytopenia. 
He underwent a bone marrow aspiration and biopsy which was 
consistent with ITP (increased megakaryopoiesis and other 
hematopoietic lineages being normal). He was started on oral 
prednisolone after which his platelet counts steadily rose to 
186,000/mm3. He was diagnosed to have secondary ITP following 
a dengue fever and continues to be on regular follow-up. All other 
known secondary causes of ITP were ruled out.
In both the above-mentioned cases, other bone marrow 
dyscrasias were ruled out by a meticulous bone marrow 
examination. Peripheral blood count and peripheral blood smear 
(to rule out pseudo-thrombocytopenia), Helicobacter pylori, HIV, 
and HCV testing were also performed and found to be negative.
DISCUSSION
During a dengue endemic, ITP can go unnoticed. It is up to the 
clinician to have a high index of suspicion and identify patients 
who do not follow the usual course of dengue fever. An ITP 
can easily imitate and confound the diagnosis of a fever and 
thrombocytopenia syndrome. Therefore, a possibility of ITP must 
be entertained if thrombocytopenia persists beyond the expected 
period of platelet count turnaround. The age-old classification of 
ITP holds true here and illustrates the complexity of the disease. 
Hence, as in the first case, primary ITP was at first deceptively 
diagnosed as a classic case of dengue, while in the second case, 
the dengue infection triggered an immunological breakdown 
following which a secondary ITP ensued.
ITP is an autoimmune disorder characterized by low platelet 
counts and bleeding. ITP being a diagnosis of exclusion does 
not do justice to the threatening virulence it carries. Antibodies 
against platelets are responsible for most cases of ITP. Although 
most cases are asymptomatic, very low platelet counts can lead 
to a bleeding diathesis. Mucocutaneous bleeds such as petechiae, 
purpura, and easy bruising are expected in ITP. Older patients 
have more severe hemorrhagic manifestations ranging from 
gastrointestinal bleeds to intracranial bleeds [10]. The nature 
of the bleeding usually corresponds to the platelet count. It is 
known that ITP can be divided between primary or secondary 
as well as acute or chronic. In adults, ITP is primary, chronic 
and idiopathic. Acute, secondary ITP is usually seen in children 
after a viral infection and is self-limiting. The causes of ITP 
are given in Table 1. The mechanisms involved in the resulting 
thrombocytopenia are given in Table 2 [11].
Clinical indicators hinting at ITP are refractory, persistent, 
prolonged thrombocytopenia, and poor response to donor platelet 
transfusions. At present, there are no scientific recommendations 
or evidence available to predict the development of secondary 
Table 1: Causes of immune thrombocytopenic purpura
Primary
Antibody mediated
Idiopathic
Secondary
Postinfectious
HIV
Hepatitis C
Helicobacter pylori
Other viral infections like CMV, EBV, dengue
Drug dependent
Quinine
Heparin
Lymphoproliferative disorders
Leukemia
Associated with vasculitis/autoimmune disorders
SLE
Rheumatoid arthritis
Antiphospholipid syndrome
Evans syndrome
Others
Postmeasles-mumps-rubella vaccination
Cirrhosis
EBV: Epstein–Barr virus, CMV: Cytomegalovirus, HIV: Human immunodeficiency 
virus, SLE: Systemic lupus erythematosus
Kodiatte and Kumar Dengue and ITP
Vol 5 | Issue 1 | Jan - Feb 2019 Indian J Case Reports 3
ITP. Nor are there any specific criteria available to formulate 
a diagnosis of ITP. Currently, the diagnostic approach is based 
essentially on a process of exclusion [12]. A failure of platelet 
count to rise well after the illness should rouse the thought of an 
ITP. Unfortunately, as it may hold true for most diseases, a high 
index of suspicion and a search for certain clinical indicators may 
be the only approach to diagnosing such a predicament. To the best 
of our knowledge, only a few authors in the past have reported an 
association with dengue and ITP, all having a dramatic response 
with corticosteroids [13-16].
CONCLUSION
Primary and secondary ITP can be a masquerader as well as an 
offspring of dengue fever. An ITP can mimic and go undetected 
and unnoticed during a dengue endemic. The physician should 
intently be on the lookout for certain telltale signs and features 
and signs that indicate an ITP in a patient presenting with a fever 
and thrombocytopenia syndrome, particularly during a dengue 
outbreak. Although an initial misdiagnosis can rarely lead to 
mortality, it can certainly stretch healthcare costs. Early detection 
and a prompt initiation of treatment need no clarification of its 
benefits. A careful assessment for clinical indicators of an ITP 
especially during a dengue endemic is vital to timely diagnosis.
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Table 2: Mechanisms of thrombocytopenia in immune 
thrombocytopenic purpura
Mechanisms of thrombocytopenia in ITP
Increased platelet destruction
Breakdown in central and peripheral immune tolerance of T cells 
and B cells
Antiplatelet antibodies against glycoprotein IIb/IIIa, resulting in 
its destruction
Drug or inactivated/live pathogen binds to platelet surface 
recruiting antibodies, thereby triggering a temporary immune 
response to platelets
Foreign antigens cross-react with platelet antigens (molecular 
mimicry)
Development of anti-platelet antibodies
Decreased platelet production
Anti-platelet antibodies also target megakaryocytes
Impaired function of megakaryocytes
Foreign antigen/virus induced bone marrow suppression
Insufficient thrombopoietin levels
ITP: Immune thrombocytopenic purpura
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